CUTANEOUS LUPUS ERYTHEMATOSUS (CLE)
Clinical trials for CUTANEOUS LUPUS ERYTHEMATOSUS (CLE) explained in plain language.
Never miss a new study
Get alerted when new CUTANEOUS LUPUS ERYTHEMATOSUS (CLE) trials appear
Sign up with your email to follow new studies for CUTANEOUS LUPUS ERYTHEMATOSUS (CLE), keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New drug trial targets painful lupus skin rash
Disease control Recruiting nowThis study is testing whether an experimental drug called VENT-03 can reduce the severity of skin rashes caused by lupus. About 24 adults with active lupus skin rashes will take either VENT-03 or a placebo for 4 weeks, then all will take VENT-03 for 8 more weeks. Researchers will…
Matched conditions: CUTANEOUS LUPUS ERYTHEMATOSUS (CLE)
Phase: PHASE2 • Sponsor: Ventus Therapeutics U.S., Inc. • Aim: Disease control
Last updated Apr 01, 2026 21:56 UTC
-
10,000 lupus patients sought for major online survey to shape future care
Knowledge-focused Recruiting nowThis is a large online registry, not a treatment study. Its purpose is to collect information directly from up to 10,000 people living with lupus to better understand their diagnosis journey, treatments, and how the disease affects their daily life and work. Participants complete…
Matched conditions: CUTANEOUS LUPUS ERYTHEMATOSUS (CLE)
Sponsor: Lupus Foundation of America • Aim: Knowledge-focused
Last updated Mar 16, 2026 15:27 UTC